Trial
NCT05359835
DTPA (Diethylenetriaminepenta-acetate) Chelation for Symptoms After Gadolinium-assisted MRI Exposure
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Gadolinium Deposition Disease
Intervention
Calcium DTPA and Zinc DTPA
Why stopped
Could not recruit subjects quickly enough
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-16